Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$0.99
-1.0%		$0.96
$0.84
▼
$2.38
$457.39M0.812.97 million shs3.60 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.21
+1.9%		$2.83
$2.28
▼
$3.43
$1.16B0.91.41 million shs1.05 million shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
▼
$115.00
$6.88B0.38180 shsN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$4.47
-0.2%		$4.50
$3.67
▼
$23.20
$636.07M1.94.95 million shs2.79 million shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-1.03%-1.03%+5.30%-3.91%-27.76%
Cronos Group Inc. stock logo
CRON
Cronos Group
+1.90%+4.22%+15.05%+20.22%+26.88%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-0.22%-6.49%+3.95%-17.38%-60.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$0.99
-1.0%		$0.96
$0.84
▼
$2.38
$457.39M0.812.97 million shs3.60 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.21
+1.9%		$2.83
$2.28
▼
$3.43
$1.16B0.91.41 million shs1.05 million shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
▼
$115.00
$6.88B0.38180 shsN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$4.47
-0.2%		$4.50
$3.67
▼
$23.20
$636.07M1.94.95 million shs2.79 million shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-1.03%-1.03%+5.30%-3.91%-27.76%
Cronos Group Inc. stock logo
CRON
Cronos Group
+1.90%+4.22%+15.05%+20.22%+26.88%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-0.22%-6.49%+3.95%-17.38%-60.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Canopy Growth Corporation stock logo
CGC
Canopy Growth
2.20
HoldN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
2.40
Hold$2.30-28.35% Downside
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00
N/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.50
Moderate Buy$11.00146.09% Upside

Current Analyst Ratings Breakdown

Latest CGC, STDAF, TLRY, and CRON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/12/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D+) ➝ Hold (C+)
8/7/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/31/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
TD Securities logo
TD Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/29/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/14/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/14/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$7.00 ➝ $5.00
6/29/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/15/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/1/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
5/29/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$251.01M1.77N/AN/A$1.13 per share0.88
Cronos Group Inc. stock logo
CRON
Cronos Group
$146.59M8.12$0.01 per share250.46$3.00 per share1.07
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$3.84B1.79$11.12 per share9.93$23.11 per share4.78
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$915.45M0.67N/AN/A$13.68 per share0.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$190.29M-$0.45N/AN/AN/A-65.33%-21.91%-14.34%11/6/2026 (Estimated)
Cronos Group Inc. stock logo
CRON
Cronos Group
-$9.45M$0.2016.05N/AN/A39.08%4.85%4.62%11/5/2026 (Estimated)
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$292.15MN/AN/AN/AN/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$121.40M-$1.08N/AN/AN/A-13.11%-7.76%-5.59%10/8/2026 (Estimated)

Latest CGC, STDAF, TLRY, and CRON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q1 2027
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$0.04-$0.02+$0.02-$0.02$58.21 million$142.62 million
8/6/2026Q2 2026
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.09+$0.08$0.09$44.20 million$53.01 million
7/28/2026Q4 2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.0120-$0.43-$0.4180-$0.43$246.30 million$281.71 million
6/15/2026Q4 2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$0.06-$0.17-$0.11-$0.05$53.43 million$51.22 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Canopy Growth Corporation stock logo
CGC
Canopy Growth
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.31
3.04
2.39
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
16.18
15.25
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
2.23
1.54
0.99
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.22
2.21
1.37

Institutional Ownership

CompanyInstitutional Ownership
Canopy Growth Corporation stock logo
CGC
Canopy Growth
3.33%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.35%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.80%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Canopy Growth Corporation stock logo
CGC
Canopy Growth
1,128448.42 million446.85 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450370.73 million341.81 millionOptionable
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
12,50062.34 millionN/ANot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
3,595136.20 million135.06 millionOptionable

Recent News About These Companies

Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
August 18 at 12:31 AM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/tilray-medical-welcomes-progress-in-germany-s-medical-cannabis-framework-and-supports-continued-policy-development-1036469997
Tilray Brands (NASDAQ: TLRY): Key Catalysts Come Into Focus
August 18 at 7:31 PM  |  kalkinemedia.comK
Top Canadian Cannabis Stocks to Watch in August 2026
August 18 at 10:00 AM  |  marijuanastocks.comM
BrewDog Unwraps Its 2026 Advent Calendar
August 18 at 7:51 AM  |  financialpost.comF
BrewDog Unwraps Its 2026 Advent Calendar
August 18 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3346716/0/en/brewdog-unwraps-its-2026-advent-calendar.html
Tilray Medical Welcomes Progress in Germany's Medical Cannabis Framework and Supports Continued Policy Development
August 18 at 7:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3346700/0/en/tilray-medical-welcomes-progress-in-germany-s-medical-cannabis-framework-and-supports-continued-policy-development.html
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note
August 17 at 12:05 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tilray-brands-inc-tlry-registers-220002959.html
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note
August 17 at 7:01 PM  |  zacks.comhttps://www.zacks.com/stock/news/2975996/tilray-brands-inc-tlry-registers-a-bigger-fall-than-the-market-important-facts-to-note?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_6v2-2975996
Tilray Brands (NASDAQ:TLRY) Shares Down 4.1% - Here's What Happened
August 17 at 5:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-shares-down-41-heres-what-happened-2026-08-17/
Tilray Brands (NASDAQ:TLRY) Shares Draw Attention Amid Global Expansion Push
August 17 at 2:03 PM  |  kalkinemedia.comK
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
August 17 at 9:03 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tilray-medical-accelerates-commercial-expansion-110000246.html
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
August 17 at 9:03 AM  |  finance.yahoo.comhttps://finance.yahoo.com/small-business/articles/montauk-brewing-company-expands-coastal-113000857.html
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
August 17 at 7:50 AM  |  financialpost.comF
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
August 17 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3345999/0/en/montauk-brewing-company-expands-its-coastal-footprint-with-new-north-shore-brewpub.html
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
August 17 at 7:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3345947/0/en/tilray-medical-accelerates-the-commercial-expansion-of-tilray-medical-branded-cannabis-medicines-in-the-uk-with-first-direct-to-patient-launch-through-lyphe-clinic-and-lyphe-dispen.html
Tilray Brands (NASDAQ:TLRY) stock in focus as cannabis beverage launch draws attention
August 16 at 1:14 AM  |  kalkinemedia.comK
Tilray Brands (NASDAQ:TLRY): Balance Sheet Moves Take Focus
August 14, 2026  |  kalkinemedia.comK
Should You Buy ACB Stock Amid Curaleaf's Hostile Takeover Attempt?
August 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/buy-acb-stock-amid-curaleafs-122400746.html
Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.
August 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/media-advertising/articles/montauk-brewing-company-announces-collaboration-110000301.html
Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344377/0/en/montauk-brewing-company-announces-new-collaboration-with-morning-brew-inc.html
Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.1% - Time to Sell?
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-stock-price-down-21-time-to-sell-2026-08-12/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Canopy Growth stock logo

Canopy Growth NASDAQ:CGC

$0.99 -0.01 (-1.03%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$0.98 -0.01 (-0.98%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$3.21 +0.06 (+1.90%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$3.13 -0.08 (-2.62%)
As of 06:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft stock logo

STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF

$110.42 0.00 (0.00%)
As of 10/24/2022

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$4.47 -0.01 (-0.22%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$4.45 -0.02 (-0.54%)
As of 06:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas